Continuing Education
Novo Nordisk Inc. supports accredited continuing education (CE) for healthcare professionals across therapeutic areas of interest. These CE activities are planned, developed and delivered by independent accredited providers in accordance with the standards set forth in the ACCME Standards for Integrity and Independence in Accredited Continuing Education, or the standards of other similar accrediting organizations. Novo Nordisk Inc. does not exercise control over, or provide guidance to, any accredited provider. Novo Nordisk Inc. is sharing CE information on this page as a service to the medical community and with permission from the accredited providers. The information on this page is intended to provide self-service to educational topics of interest and most activities are free to the learner (some may require a nominal registration fee per the accredited provider’s requirements).
Click below to filter results by Therapeutic Area.
We didn't find any resources that match your selection.
Please adjust your filter(s) and try again.
Diabetes
GLP-1 RAs: Selecting the Right Patient at the Right Time
Expiration Date: April 14, 2027
Decision Points in Diabetes: Putting Patient-Centered Technologies into Practice
Expiration Date: October 16, 2024
The Evolving Role of GLP-1 RAs in Patients with Type 2 Diabetes (Part 1 of a 2-Part Series)
Expiration Date: October 17, 2024
Putting Patients First: Incorporating GLP-1 RAs in T2DM Care
Expiration Date: October 26, 2024
Understanding and Reducing Cardiovascular and Cardiometabolic Risks
Expiration Date: October 30, 2024
Euglycemia: Benefits of Glucose Control on Health Outcomes
Expiration Date: October 30, 2024
GLP-1 RAs: Real-World Patient-Care Strategies for Type 2 Diabetes
Expiration Date: October 31, 2024
Medical Minute 1: Assessing the Need to Integrate GLP-1 RAs Into Cardiology Practice
Expiration Date: November 9, 2024
Medical Minute 2: Cardiovascular Risk Reduction Strategies With GLP-1 Receptor Agonists
Expiration Date: November 12, 2024
Patient POV: GLP-1 Receptor Agonists in Type 2 Diabetes Mellitus
Expiration Date: November 14, 2024
Expiration Date: November 16, 2024
Clinical Advantage Bootcamp: Type 2 Diabetes Management Certificate for Nurse Practitioners
Expiration Date: December 31, 2024
The Diabetes Armamentarium: Putting Patient-centered Technologies into Practice
Expiration Date: November 15, 2024
Patient-Centric Management of Diabetes: The Evolving Role of GLP-1 Ras
Expiration Date: November 1, 2024
The Role of Basal Insulin in the Modern Era of Diabetes Management: Interactive Case Challenge 1
Expiration Date: October 25, 2024
The Role of Basal Insulin in the Modern Era of Diabetes Management: Interactive Case Challenge 2
Expiration Date: October 25, 2024
Can You Crack the Case? A Diabetes Patient Simulation
Expiration Date: October 27, 2024
Overlap of Pathophysiology and Epidemiology of Type 2 Diabetes and Concomitant CKD
Expiration Date: November 29, 2024
Expiration Date: November 29, 2024
Management of a Patient With Type 2 Diabetes, Stage 3B CKD, and Heart Failure Symptoms
Expiration Date: November 29, 2024
Glucagon-Like Peptide-1 Receptor Agonists Are Becoming Important Players in Diabetic Kidney Disease
Expiration Date: December 31, 2024
Optimizing Patient-Centered Outcomes in Type 2 Diabetes with GLP-1 RA Therapy
Expiration Date: December 20, 2024
GLP-1 Agonists: Mechanisms to Applications with Dr. Dennis Bruemmer
Expiration Date: June 1, 2025
The Evolving Role of GLP-1 RAs in Patients with Type 2 Diabetes
Expiration Date: December 15, 2024
Treatment and Management of T2D with GLP-1 RAs: Patient Care Experience
Expiration Date: December 31, 2024
Recognizing and Managing Endocrine Metabolic Disease in Practice
Expiration Date: January 24, 2025
Clinical Questions in Cardiology: Using Glucagon-like Peptide-1 Receptor Agonists
Expiration Date: January 31, 2025
Chronic Kidney Disease and GLP-1 Ras
Expiration Date: September 10, 2026
GLP-1 Agonists: Diving Into the Data With Dr. Darren McGuire
Expiration Date: December 1, 2024
Expiration Date: April 12, 2025
GLP-1 Agonists: Clinical Implementation of GLP-1 Receptor Agonists with Dr. Neha Pagidapati
Expiration Date: May 3, 2025
Expiration Date: May 25, 2027
Putting Evidence into Practice: Tips for Starting and Continuing GLP-1 RAs
Expiration Date: June 13, 2027
Expert Insights on Managing T2D With GLP-1 RAs
Expiration Date: June 28, 2025
A Holistic Approach: Tailoring T2D Therapy With GLP-1 RAs
Expiration Date: June 28, 2025
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
Expiration Date: April 30, 2025
Addressing Underutilization of Cardioprotective GLP-1 RAs for T2D in Specialty Practice
Expiration Date: July 31, 2025
Expiration Date: August 6, 2025
A Community Pharmacy’s Guide to the Evolving Role of GLP-1 Receptor Agonists for Diabetes
Expiration Date: August 22, 2027
Obesity
Best of Obesity Forum: Personalizing Management and Case Challenges
Expiration Date: October 30, 2024
Best of Obesity Forum: Conversations in Obesity Care
Expiration Date: October 30, 2024
Expiration Date: February 26, 2025
Practical Conversations: Improving Health Outcomes in Women with Obesity
Expiration Date: November 21, 2024
Expiration Date: December 26, 2024
Expiration Date: December 21, 2024
Obesity and Cardiology: Defining the Link and Examining Treatments
Expiration Date: December 27, 2024
Endocrine Society Obesity Fellows Program
Expiration Date: December 31, 2024
Endocrine Society Obesity Fellows Program
Expiration Date: December 31, 2024
Expiration Date: December 20, 2024
Overcoming the Challenges of Managing Obesity: PatientSimX Case Simulations
Expiration Date: December 28, 2024
Obesity & Cardiovascular Disease Risk with Dr. Jaime Almandoz
Expiration Date: January 7, 2025
Expiration Date: January 10, 2027
Lifestyle & Pharmacologic Management of Obesity
Expiration Date: December 20, 2024
Clinical Case Studies: Best Practices for the Use of Pharmacotherapy in Obesity
Expiration Date: February 26, 2025
Chief Resident Summit on Obesity
Expiration Date: February 1, 2025
Mechanisms, Pathophysiology, and Management of Obesity
Expiration Date: March 21, 2027
Expiration Date: April 25, 2025
368. Obesity: Procedural Management of Obesity
Expiration Date: May 1, 2025
The Evolution of Our Understanding of Obesity and Implications for CVD
Expiration Date: March 31, 2025
Recent Advancements in the Management of Obesity with a Focus on Pharmacotherapies
Expiration Date: May 30, 2025
Managing Obesity & Cardiovascular Risk with GLP-1 RAs
Expiration Date: June 28, 2025
Management of Complications of Obesity
Expiration Date: June 20, 2025
Practical Strategies for Obesity Management in Primary Care
Expiration Date: December 31, 2025
Managing Obesity in Adolescent Patients: Your Top 10 Questions Answered
Expiration Date: August 15, 2025
Pharmacological and Surgical Management of Obesity
Expiration Date: June 25, 2027
Shifting Perspectives in Obesity Management: A Call to Action for Cardiologists
Expiration Date: August 29, 2025
Lifestyle and Behavioral Management of Obesity
Expiration Date: March 31, 2025
Obesity Management Considerations in Diverse Populations
Expiration Date: August 27, 2027
Cardiovascular Disease
Two Diseases, One Approach: Targeting Inflammation in ASCVD and CKD
Expiration Date: April 18, 2025
Connecting the Dots: Inflammation’s Impact on ASCVD and CKD
Expiration Date: April 30, 2025
Expert Insights on Targeting Residual Inflammatory Risk in ASCVD and CKD
Expiration Date: July 21, 2025
Inflammation Unveiled – Tackling Residual Risk in ASCVD and CKD
Expiration Date: September 4, 2025
Expiration Date: August 22, 2025
Management of ASCVD in Patients with CKD: Present, Past, and Future (Module 2)
Expiration Date: August 28, 2025
Exploring the Link Between Systemic Inflammation, Atherosclerosis, and CKD (Module 1)
Expiration Date: August 30, 2025
Inflammation Unveiled – Tackling Residual Risk in ASCVD and CKD
Expiration Date: September 4, 2025
Liver Health
Expiration Date: October 17, 2024
Does Your Patient Have Steatotic Liver Disease? A Virtual Patient Challenge
Expiration Date: October 27, 2024
Targeting the Metabolic Mechanisms of MASLD and MASH: A Fresh Horizon for Improved Outcomes
Expiration Date: November 1, 2025
A Metabolic Approach to MASH Management: Adipose Tissue as a Metabolic Organ
Expiration Date: December 11, 2024
Expiration Date: December 28, 2025
MASLD/MASH Screening and Diagnosis
Expiration Date: December 28, 2024
Clinical Care Pathway: A Framework for Managing MASLD/MASH
Expiration Date: January 30, 2025
AGA Clinical Care Pathway: Guide to Screening and Managing MASLD/MASH
Expiration Date: February 5, 2025
Advances in MASLD/MASH Therapeutics and Updates to the Development Pipeline
Expiration Date: March 12, 2025
Expiration Date: February 13, 2025
Encountering and managing MASLD/MASH
Expiration Date: April 18, 2025
Expert Perspectives: Post Conference Highlights on MASLD/MASH
Expiration Date: December 31, 2025
Experts vs AI: Who Is Better at Monitoring and Treating MASLD and MASH?
Expiration Date: June 19, 2025
Endocrinologists and PCPs: The Frontline Defense Against Cirrhosis in Patients with Type 2 Diabetes
Expiration Date: June 13, 2025
Redefining MASLD/MASH Care: Personalized Strategies for Assessment, Diagnosis, and Management
Expiration Date: June 12, 2025
Ace The Case #2 - A 60-Year-Old Type 2 Diabetic Woman with Mash and F3 Liver Fibrosis
Expiration Date: June 19, 2025
Ace The Case #1 – A 37-Year-Old Man with Incidental Hepatic Steatosis on Abdominal Ultrasound
Expiration Date: June 19, 2025
Expert Perspectives – Post Conference Highlights on MASLD/MASH
Expiration Date: July 11, 2025
Expiration Date: July 3, 2025
Expiration Date: July 2, 2025
Patient-Centric Care: Tailoring MASLD Management for Optimal Outcomes
Expiration Date: September 30, 2025
MASH Academy: How to Identify Patients with MASH at risk of Mortality
Expiration Date: May 31, 2025
MASH Academy: Updates in Metabolic Dysfunction-Associated Steatohepatitis Management
Expiration Date: May 31, 2025
Identifying Complications in Metabolic Dysfunction-Associated Steatohepatitis
Expiration Date: May 31, 2025
MASH Forum Case: Advanced Care Strategies for MASH
Expiration Date: May 31, 2025
Neuro Health
We are still gathering material for this section. Please check again soon.
Rare Bleeding Disorders
Expiration Date: December 31, 2024
Expiration Date: February 21, 2025
Integrating Novel Therapies in Hemophilia in the Midst of Bridging Health Inequities
Expiration Date: May 14, 2025
Latest Developments in the Treatment of Hemophilia: Focus on Anti-Tissue Factor Pathway Inhibitors
Expiration Date: June 4, 2025
Improving the Patient Experience: Emerging Therapies (Episode 3)
Expiration Date: July 22, 2025
Improving the Patient Experience: New Therapies (Episode 2)
Expiration Date: July 22, 2025
The Burden of Living with Hemophilia (Episode 1)
Expiration Date: July 22, 2025
Racial and Ethnic Disparities in the Context of New and Emerging Treatments for Hemophilia
Expiration Date: July 22, 2025
Does Labeling the Level of Severity in Hemophilia Block Access to Optimized Care?
Expiration Date: July 12, 2025
Exploring Non-Factor Replacement Therapies for Hemophilia Care: Achieving Positive Outcomes
Expiration Date: August 22, 2025
Rare Endocrine Disorders
Expiration Date: November 20, 2024
Rare Renal Disorders
Diagnosis and Management of Primary Hyperoxaluria Type 1: An Interactive Case Challenge
Expiration Date: December 11, 2024
Medical Minute 1 – It Might be a Zebra: Clinical Suspicion for Primary Hyperoxaluria Type 1
Expiration Date: December 25, 2024
Medical Minute 3 – Conventional and New Therapies for Primary Hyperoxaluria Type 1
Expiration Date: January 15, 2025
Hemoglobinopathies
We are still gathering material for this section. Please check again soon.
Find more information
Speak to a medical representative
If you are a healthcare provider from the United States, click below to request information directly from the Novo Nordisk Medical Information department. If you are a patient, please visit here to contact us, or call 1-800-727-6500.
Search the Medical Information Database
The Scientific Exchange is a resource for U.S. Healthcare Professionals to learn more about disease states investigated by Novo Nordisk and our related products.
The purpose of this site is to provide relevant medical and scientific information about Novo Nordisk products and areas of therapeutic interest. Information about investigational products or investigational uses of approved products neither implies FDA approval for these products or uses, nor establishes the safety or efficacy of these products or uses. There is no guarantee that any investigational product or investigational use will receive FDA approval or become commercially available in the United States. Novo Nordisk does not recommend or suggest use of its products in any manner inconsistent with FDA-approved labeling.
This site is intended for United States healthcare professionals only. The information on this site—including all product information—pertains to residents of the United States only. Any products referenced on this site may have different labelling in different countries.
